Skip to main content
Erschienen in: Journal of Cardiovascular Translational Research 3/2015

01.04.2015

Enhancing the Predictive Power of Mutations in the C-Terminus of the KCNQ1-Encoded Kv7.1 Voltage-Gated Potassium Channel

verfasst von: Jamie D. Kapplinger, Andrew S. Tseng, Benjamin A. Salisbury, David J. Tester, Thomas E. Callis, Marielle Alders, Arthur A. M. Wilde, Michael J. Ackerman

Erschienen in: Journal of Cardiovascular Translational Research | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Despite the overrepresentation of Kv7.1 mutations among patients with a robust diagnosis of long QT syndrome (LQTS), a background rate of innocuous Kv7.1 missense variants observed in healthy controls creates ambiguity in the interpretation of LQTS genetic test results. A recent study showed that the probability of pathogenicity for rare missense mutations depends in part on the topological location of the variant in Kv7.1’s various structure-function domains. Since the Kv7.1’s C-terminus accounts for nearly 50 % of the overall protein and nearly 50 % of the overall background rate of rare variants falls within the C-terminus, further enhancement in mutation calling may provide guidance in distinguishing pathogenic long QT syndrome type 1 (LQT1)-causing mutations from rare non-disease-causing variants in the Kv7.1’s C-terminus. Therefore, we have used conservation analysis and a large case-control study to generate topology-based estimative predictive values to aid in interpretation, identifying three regions of high conservation within the Kv7.1’s C-terminus which have a high probability of LQT1 pathogenicity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Wang, Q., Curran, M. E., Splawski, I., Burn, T. C., Millholland, J. M., VanRaay, T. J., Shen, J., Timothy, K. W., Vincent, G. M., de Jager, T., Schwartz, P. J., Toubin, J. A., Moss, A. J., Atkinson, D. L., Landes, G. M., Connors, T. D., & Keating, M. T. (1996). Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nature Genetics, 12(1), 17–23.CrossRefPubMed Wang, Q., Curran, M. E., Splawski, I., Burn, T. C., Millholland, J. M., VanRaay, T. J., Shen, J., Timothy, K. W., Vincent, G. M., de Jager, T., Schwartz, P. J., Toubin, J. A., Moss, A. J., Atkinson, D. L., Landes, G. M., Connors, T. D., & Keating, M. T. (1996). Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nature Genetics, 12(1), 17–23.CrossRefPubMed
4.
Zurück zum Zitat Kapa, S., Tester, D. J., Salisbury, B. A., Harris-Kerr, C., Pungliya, M. S., Alders, M., Wilde, A. A., & Ackerman, M. J. (2009). Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation, 120(18), 1752–1760.CrossRefPubMedCentralPubMed Kapa, S., Tester, D. J., Salisbury, B. A., Harris-Kerr, C., Pungliya, M. S., Alders, M., Wilde, A. A., & Ackerman, M. J. (2009). Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation, 120(18), 1752–1760.CrossRefPubMedCentralPubMed
5.
Zurück zum Zitat Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., Rehm, H. L., Watson, M. S., Williams, M. S., & Biesecker, L. G. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 15(7), 565–574. doi:10.1038/gim.2013.73.CrossRef Green, R. C., Berg, J. S., Grody, W. W., Kalia, S. S., Korf, B. R., Martin, C. L., McGuire, A. L., Nussbaum, R. L., O’Daniel, J. M., Ormond, K. E., Rehm, H. L., Watson, M. S., Williams, M. S., & Biesecker, L. G. (2013). ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genetics in Medicine: Official Journal of the American College of Medical Genetics, 15(7), 565–574. doi:10.​1038/​gim.​2013.​73.CrossRef
6.
Zurück zum Zitat Giudicessi, J. R., Kapplinger, J. D., Tester, D. J., Alders, M., Salisbury, B. A., Wilde, A. A. M., & Ackerman, M. J. (2012). Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome. Circulation-Cardiovascular Genetics, 5(5), 519–528.CrossRefPubMedCentralPubMed Giudicessi, J. R., Kapplinger, J. D., Tester, D. J., Alders, M., Salisbury, B. A., Wilde, A. A. M., & Ackerman, M. J. (2012). Phylogenetic and physicochemical analyses enhance the classification of rare nonsynonymous single nucleotide variants in type 1 and 2 long-QT syndrome. Circulation-Cardiovascular Genetics, 5(5), 519–528.CrossRefPubMedCentralPubMed
7.
Zurück zum Zitat Abecasis, G. R., Auton, A., Brooks, L. D., DePristo, M. A., Durbin, R. M., Handsaker, R. E., Kang, H. M., Marth, G. T., & McVean, G. A. (2012). An integrated map of genetic variation from 1,092 human genomes. Nature, 491(7422), 56–65. doi:10.1038/nature11632.CrossRefPubMed Abecasis, G. R., Auton, A., Brooks, L. D., DePristo, M. A., Durbin, R. M., Handsaker, R. E., Kang, H. M., Marth, G. T., & McVean, G. A. (2012). An integrated map of genetic variation from 1,092 human genomes. Nature, 491(7422), 56–65. doi:10.​1038/​nature11632.CrossRefPubMed
8.
Zurück zum Zitat Wiener, R., Haitin, Y., Shamgar, L., Fernandez-Alonso, M. C., Martos, A., Chomsky-Hecht, O., Rivas, G., Attali, B., & Hirsch, J. A. (2008). The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit assembly and protein interaction. Journal of Biological Chemistry, 283(9), 5815–5830. doi:10.1074/jbc.M707541200.CrossRefPubMed Wiener, R., Haitin, Y., Shamgar, L., Fernandez-Alonso, M. C., Martos, A., Chomsky-Hecht, O., Rivas, G., Attali, B., & Hirsch, J. A. (2008). The KCNQ1 (Kv7.1) COOH terminus, a multitiered scaffold for subunit assembly and protein interaction. Journal of Biological Chemistry, 283(9), 5815–5830. doi:10.​1074/​jbc.​M707541200.CrossRefPubMed
9.
Zurück zum Zitat Tester, D. J., Will, M. L., Haglund, C. M., & Ackerman, M. J. (2005). Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm, 2(5), 507–517.CrossRefPubMed Tester, D. J., Will, M. L., Haglund, C. M., & Ackerman, M. J. (2005). Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm, 2(5), 507–517.CrossRefPubMed
10.
Zurück zum Zitat Kapplinger, J. D., Tester, D. J., Salisbury, B. A., Carr, J. L., Harris-Kerr, C., Pollevick, G. D., Wilde, A. A., & Ackerman, M. J. (2009). Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm, 6(9), 1297–1303.CrossRefPubMedCentralPubMed Kapplinger, J. D., Tester, D. J., Salisbury, B. A., Carr, J. L., Harris-Kerr, C., Pollevick, G. D., Wilde, A. A., & Ackerman, M. J. (2009). Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm, 6(9), 1297–1303.CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Refsgaard, L., Holst, A. G., Sadjadieh, G., Haunso, S., Nielsen, J. B., & Olesen, M. S. (2012). High prevalence of genetic variants previously associated with LQT syndrome in new exome data. European Journal of Human Genetics: EJHG, 20(8), 905–908. doi:10.1038/ejhg.2012.23.CrossRefPubMedCentralPubMed Refsgaard, L., Holst, A. G., Sadjadieh, G., Haunso, S., Nielsen, J. B., & Olesen, M. S. (2012). High prevalence of genetic variants previously associated with LQT syndrome in new exome data. European Journal of Human Genetics: EJHG, 20(8), 905–908. doi:10.​1038/​ejhg.​2012.​23.CrossRefPubMedCentralPubMed
13.
Zurück zum Zitat Ware, J. S., Walsh, R., Cunningham, F., Birney, E., & Cook, S. A. (2012). Paralogous annotation of disease-causing variants in long QT syndrome genes. Human Mutation, 33(8), 1188–1191. doi:10.1002/humu.22114.CrossRefPubMed Ware, J. S., Walsh, R., Cunningham, F., Birney, E., & Cook, S. A. (2012). Paralogous annotation of disease-causing variants in long QT syndrome genes. Human Mutation, 33(8), 1188–1191. doi:10.​1002/​humu.​22114.CrossRefPubMed
14.
Zurück zum Zitat Zheng, R., Thompson, K., Obeng-Gyimah, E., Alessi, D., Chen, J., Cheng, H., & McDonald, T. V. (2010). Analysis of the interactions between the C-terminal cytoplasmic domains of KCNQ1 and KCNE1 channel subunits. Biochemical Journal, 428(1), 75–84. doi:10.1042/BJ20090977.CrossRefPubMedCentralPubMed Zheng, R., Thompson, K., Obeng-Gyimah, E., Alessi, D., Chen, J., Cheng, H., & McDonald, T. V. (2010). Analysis of the interactions between the C-terminal cytoplasmic domains of KCNQ1 and KCNE1 channel subunits. Biochemical Journal, 428(1), 75–84. doi:10.​1042/​BJ20090977.CrossRefPubMedCentralPubMed
15.
Zurück zum Zitat Schmitt, N., Calloe, K., Nielsen, N. H., Buschmann, M., Speckmann, E. J., Schulze-Bahr, E., & Schwarz, M. (2007). The novel C-terminal KCNQ1 mutation M520R alters protein trafficking. Biochemical and Biophysical Research Communications, 358(1), 304–310. doi:10.1016/j.bbrc.2007.04.127.CrossRefPubMed Schmitt, N., Calloe, K., Nielsen, N. H., Buschmann, M., Speckmann, E. J., Schulze-Bahr, E., & Schwarz, M. (2007). The novel C-terminal KCNQ1 mutation M520R alters protein trafficking. Biochemical and Biophysical Research Communications, 358(1), 304–310. doi:10.​1016/​j.​bbrc.​2007.​04.​127.CrossRefPubMed
16.
17.
Zurück zum Zitat Wedekind, H., Schwarz, M., Hauenschild, S., Djonlagic, H., Haverkamp, W., Breithardt, G., Wulfing, T., Pongs, O., Isbrandt, D., & Schulze-Bahr, E. (2004). Effective long-term control of cardiac events with beta-blockers in a family with a common LQT1 mutation. Clinical Genetics, 65(3), 233–241.CrossRefPubMed Wedekind, H., Schwarz, M., Hauenschild, S., Djonlagic, H., Haverkamp, W., Breithardt, G., Wulfing, T., Pongs, O., Isbrandt, D., & Schulze-Bahr, E. (2004). Effective long-term control of cardiac events with beta-blockers in a family with a common LQT1 mutation. Clinical Genetics, 65(3), 233–241.CrossRefPubMed
18.
Zurück zum Zitat Kapplinger, J. D., Landstrom, A. P., Bos, J. M., Salisbury, B. A., Callis, T. E., & Ackerman, M. J. (2014). Distinguishing hypertrophic cardiomyopathy-associated mutations from background genetic noise. Journal of Cardiovascular Translational Research, 7(3), 347–361. doi:10.1007/s12265-014-9542-z.CrossRefPubMed Kapplinger, J. D., Landstrom, A. P., Bos, J. M., Salisbury, B. A., Callis, T. E., & Ackerman, M. J. (2014). Distinguishing hypertrophic cardiomyopathy-associated mutations from background genetic noise. Journal of Cardiovascular Translational Research, 7(3), 347–361. doi:10.​1007/​s12265-014-9542-z.CrossRefPubMed
Metadaten
Titel
Enhancing the Predictive Power of Mutations in the C-Terminus of the KCNQ1-Encoded Kv7.1 Voltage-Gated Potassium Channel
verfasst von
Jamie D. Kapplinger
Andrew S. Tseng
Benjamin A. Salisbury
David J. Tester
Thomas E. Callis
Marielle Alders
Arthur A. M. Wilde
Michael J. Ackerman
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Journal of Cardiovascular Translational Research / Ausgabe 3/2015
Print ISSN: 1937-5387
Elektronische ISSN: 1937-5395
DOI
https://doi.org/10.1007/s12265-015-9622-8

Weitere Artikel der Ausgabe 3/2015

Journal of Cardiovascular Translational Research 3/2015 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.